47 research outputs found

    Review of Student Profile Management System Using QR Code

    Get PDF
    The QR code has gained a lot of popularity these days. With the rapid growth in information technology, the QR code has made their way in to the world. The quick response code is a two dimensional barcode as it is evolved from barcode. They come in various shapes and size. They are multidimensional and can also come in coloured form. The main purposed of the QR code is directing the user to a particular link. Since the use of mobile has increased, they have become very popular among the mobile users. Presently, smart phones come at much affordable prices because of which almost every person on the planet has a mobile phone which also includes the student population. This facilitates the QR code in the educational system. In this paper, we are suggesting a way of management of student?s record by creating a Student profile using his basic registration information. This profile can be simultaneously updated. The purpose of this system is to eliminate the gap between the student and the institutional management. This is not only an efficient profile management system but also reduces the problem of queue, wastage of time and reduction in paper consumption. This way, there is a smoother and systematic management at the student?s side as well as the administration side

    Early growth performance of terminalia subspathulata king in a spacing and fertiliser trial at segaliud lokan forest reserve Sandakan, Sabah

    Get PDF
    Terminalia subspathulata is an introduced tree species proposed for enrichment planting at Segaliud Lokan Forest Reserve (SLFR) Sandakan, Sabah. The objective of this study is to assess the early growth performance of T. Subspathulata in a spacing and fertiliser trial. A Randomised Complete Block Design (RCBD) trial with three block replicates (spacing), and three plot replicates (fertiliser) respectively was established on moderately degraded forest site. The height, collar diameter, number of leaves and survival of seedlings were recorded monthly and analysed based on four months of data collected. The average survival rate of early growth performance of T. Subspathulata was more than 88%. The Analysis of Variance (ANOVA) showed that there were significant differences (P < 0.05) for the mean collar diameter (P = 0.011), the number of leaves ( P = 0.034) between the spacing treatments, and the mean height (P = 0.043) of T. subspathulata between the fertiliser treatments. The combination treatments of different spacing and fertiliser at four months after planting showed significant differences between the mean number of leaves (P = 0.024). The preliminarily report signifying the effect of spacing and fertiliser treatments on the early growth of T. Subspathulata samples assessed

    Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

    Get PDF

    Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

    Get PDF
    Background and purpose: Prospectively collected data comparing the safety and effectiveness of individual non-vitamin K antagonists (NOACs) are lacking. Our objective was to directly compare the effectiveness and safety of NOACs in patients with newly diagnosed atrial fibrillation (AF). Methods: In GLORIA-AF, a large, prospective, global registry program, consecutive patients with newly diagnosed AF were followed for 3&nbsp;years. The comparative analyses for (1) dabigatran vs rivaroxaban or apixaban and (2) rivaroxaban vs apixaban were performed on propensity score (PS)-matched patient sets. Proportional hazards regression was used to estimate hazard ratios (HRs) for outcomes of interest. Results: The GLORIA-AF Phase III registry enrolled 21,300 patients between January 2014 and December 2016. Of these, 3839 were prescribed dabigatran, 4015 rivaroxaban and 4505 apixaban, with median ages of 71.0, 71.0, and 73.0&nbsp;years, respectively. In the PS-matched set, the adjusted HRs and 95% confidence intervals (CIs) for dabigatran vs rivaroxaban were, for stroke: 1.27 (0.79–2.03), major bleeding 0.59 (0.40–0.88), myocardial infarction 0.68 (0.40–1.16), and all-cause death 0.86 (0.67–1.10). For the comparison of dabigatran vs apixaban, in the PS-matched set, the adjusted HRs were, for stroke 1.16 (0.76–1.78), myocardial infarction 0.84 (0.48–1.46), major bleeding 0.98 (0.63–1.52) and all-cause death 1.01 (0.79–1.29). For the comparison of rivaroxaban vs apixaban, in the PS-matched set, the adjusted HRs were, for stroke 0.78 (0.52–1.19), myocardial infarction 0.96 (0.63–1.45), major bleeding 1.54 (1.14–2.08), and all-cause death 0.97 (0.80–1.19). Conclusions: Patients treated with dabigatran had a 41% lower risk of major bleeding compared with rivaroxaban, but similar risks of stroke, MI, and death. Relative to apixaban, patients treated with dabigatran had similar risks of stroke, major bleeding, MI, and death. Rivaroxaban relative to apixaban had increased risk for major bleeding, but similar risks for stroke, MI, and death. Registration: URL: https://www.clinicaltrials.gov. Unique identifiers: NCT01468701, NCT01671007. Date of registration: September 2013

    Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation. the GLORIA-AF registry

    Get PDF
    Aim: The SAMe-TT2R2 score helps identify patients with atrial fibrillation (AF) likely to have poor anticoagulation control during anticoagulation with vitamin K antagonists (VKA) and those with scores &gt;2 might be better managed with a target-specific oral anticoagulant (NOAC). We hypothesized that in clinical practice, VKAs may be prescribed less frequently to patients with AF and SAMe-TT2R2 scores &gt;2 than to patients with lower scores. Methods and results: We analyzed the Phase III dataset of the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF), a large, global, prospective global registry of patients with newly diagnosed AF and ≥1 stroke risk factor. We compared baseline clinical characteristics and antithrombotic prescriptions to determine the probability of the VKA prescription among anticoagulated patients with the baseline SAMe-TT2R2 score &gt;2 and ≤ 2. Among 17,465 anticoagulated patients with AF, 4,828 (27.6%) patients were prescribed VKA and 12,637 (72.4%) patients an NOAC: 11,884 (68.0%) patients had SAMe-TT2R2 scores 0-2 and 5,581 (32.0%) patients had scores &gt;2. The proportion of patients prescribed VKA was 28.0% among patients with SAMe-TT2R2 scores &gt;2 and 27.5% in those with scores ≤2. Conclusions: The lack of a clear association between the SAMe-TT2R2 score and anticoagulant selection may be attributed to the relative efficacy and safety profiles between NOACs and VKAs as well as to the absence of trial evidence that an SAMe-TT2R2-guided strategy for the selection of the type of anticoagulation in NVAF patients has an impact on clinical outcomes of efficacy and safety. The latter hypothesis is currently being tested in a randomized controlled trial. Clinical trial registration: URL: https://www.clinicaltrials.gov//Unique identifier: NCT01937377, NCT01468701, and NCT01671007

    The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Get PDF
    Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase&nbsp;1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation&nbsp;disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age&nbsp; 6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score&nbsp; 652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc&nbsp;= 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N&nbsp;= 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in&nbsp;Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in&nbsp;Asia&nbsp;and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

    Structural Design and Analysis of Steering Clevis Joint of an ATV For Weight Reduction Steering Stability

    Full text link
    The weight of the vehicle is going on increasing due to additional luxurious and safety features. The increasing weight affects the performance of the vehicle. Clevis joints are mostly used as an extension to steering rack to drive the power of steering rack to the tie rods of the vehicle. There are various parameters that affects the connection of steering rack directly to tie rods. Hence clevis joint are used as an attachment to the rack which are able to change the position of the tie rods of an ATV accordingly control the necessary steering arm angle and conclusively tie rod angle with respect to the steering assembly . This paper is based on custom clevis joint. Typically design software CATIA amp Solidworks is utilized to achieve the purpose. ANSYS is used for analyzing the component

    The response of bird diversity on reduced impact logging in segaluid lokan forest reserve

    Get PDF
    Forest is one of the vital revenues in South Asia especially for developing countries. Reduced Impact Logging (RIL) was developed due to the need of improving forest management on the international fora due to the continuing deforestation. Birds are one of the important taxa of tropical ecosystems. Bird community also act as one of the agents in balancing the ecosystem by control the pest population in the forest. Timber harvest system such as RIL considered as a logging activity that can reduce negative impacts on biodiversity. Logging activities may give uncertain effect on avian community. This study investigates the species diversity during pre-harvest, harvest and post-harvest period in order to study the immediate response of avian community on RIL. The study site that was selected for this research was at Segaliud Lokan Forest Reserve, Sabah. Methods used for this study was adopted from past research on bird studies using line transect of which point count stations were established. The data collection during the pre-harvest was conducted from October 2017 to April 2018. The bird population diversity was analyzed using Shannon-Weiner index of diversity and Diversity test was employed test for significant differences between pre-harvest with harvest period; and between pre-harvest with post-harvest period. The Shannon-Weiner diversity index at post-harvest (H’= 0.39) was lower as compared to that at harvest (H’= 4.27) and Post -harvest (4.24). The results of the diversity t -test for birds between pre-harvest and harvest was very significantly different (t = 5.7978; df = 944.19; p = 9.1574E-09**) and between pre-harvest and post-harvest was also very significantly different (t = 5.8713; df = 951.99; p = 5.9668E-09**). The study shows the bird responded during the RIL and soon after RIL operation by the increased of their species diversity as they were flushed out from their normal territory
    corecore